Vivesto AB

Stocks

Delayed Nasdaq Stockholm 01:13:25 30/10/26 am AEDT			5-day change	1st Jan Change
7.990 ^SEK	+5.13%		+10.66%	-40.81%

20/10	15 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
13/10	Vivesto to present positive study data for Paccal Vet at veterinary congress	FW

Published on 11/25/2025 at 03:35 am AEDT - Modified on 11/25/2025 at 09:40 am AEDT

S&P Capital IQ

Presenter Speech
Mikael Magnusson (Attendees)

The clock strikes 3:00 p.m., and we welcome viewers here to Vivesto's business update. Today, we will hear about the company with a focus towards the

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

20/10	15 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
13/10	Vivesto to present positive study data for Paccal Vet at veterinary congress	FW
24/09	Vivesto to present Paccal Vet data at conference	FW
24/09	Vivesto AB Presents Paccal Vet Data At The Veterinary Cancer Society Annual Conference 2026	CI
17/09	Vivesto sees tumor effect with Paccal Vet in cat study	FW
17/09	Vivesto reports positive topline results from the Paccal Vet feline study	FW
17/09	Vivesto Reports Positive Paccal Vet Cat Topline Results Supporting Continued Clinical Development	CI
15/09	Vivesto reports positive topline results in pilot dog study (update)	FW
15/09	Vivesto reports positive topline results in pilot dog study	FW
15/09	Vivesto AB Reports Positive Topline Results from Clinical Pilot Study Evaluating Paccal Vet in Dogs with Splenic Hemangiosarcoma Following Splenectomy	CI
13/08	Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan	FW
13/08	Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
13/08	Calendar for Thursday, August 13	FW
07/07	Vivesto chairman Peter Zonabend increases his shareholding	FW
01/07	Vivesto Completes Enrollment in Cat Study of Paccal Vet	FW

Duration

Period

Sector